The 2007 WHO Classification of Tumours of the Central Nervous System

@article{Louis2007The2W,
  title={The 2007 WHO Classification of Tumours of the Central Nervous System},
  author={David N Louis and Hiroko Ohgaki and Otmar Dieter Wiestler and Webster K. Cavenee and Peter C. Burger and Anne Jouvet and Bernd W. Scheithauer and Paul Kleihues},
  journal={Acta Neuropathologica},
  year={2007},
  volume={114},
  pages={97 - 109}
}
The fourth edition of the World Health Organization (WHO) classification of tumours of the central nervous system, published in 2007, lists several new entities, including angiocentric glioma, papillary glioneuronal tumour, rosette-forming glioneuronal tumour of the fourth ventricle, papillary tumour of the pineal region, pituicytoma and spindle cell oncocytoma of the adenohypophysis. Histological variants were added if there was evidence of a different age distribution, location, genetic… 
[WHO classification of tumours of the CNS: revised edition of 2007 with critical comments on the typing und grading of common-type diffuse gliomas].
TLDR
The typing und grading of common-type diffuse gliomas, as well as the WHO grading system, are critically reviewed, particularly with regard to the prognostically important differential diagnosis of diffuse astrocytomas und oligodendrogliomas.
The 2007 WHO ClassiWcation of Tumours of the Central Nervous System
The fourth edition of the World Health Organi- zation (WHO) classiWcation of tumours of the central ner- vous system, published in 2007, lists several new entities, including angiocentric glioma,
Newly Codified Glial Neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: Angiocentric Glioma, Pilomyxoid Astrocytoma and Pituicytoma
TLDR
Three new tumours, angiocentric glioma (AG), pilomyxoid astrocytoma (PMA), and pituicytoma are added to the section on gliomas.
Tumors of the Central Nervous System
TLDR
The authors have integrated all of these new findings, as well as classical morphological, clinical, and neuroradiological descriptions and illustrations, into an entirely new and completely up-to-date volume that demystifies the complex subject of CNS tumours and tumour-like lesions for general pathologists.
The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
  • T. Komori
  • Medicine
    Neurologia medico-chirurgica
  • 2017
The updated 2016 edition of the World Health Organization (WHO) Classification of Tumours of the Central Nervous System (CNS) uses molecular parameters and the histology to define the main tumor
Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition.
TLDR
A number of established brain tumors are reorganized, including medulloblastomas and primitive neuroectodermal tumors, in an attempt to more closely align classification with current understanding of central nervous system neoplasia.
The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas
The classification of central nervous system tumours has more recently been shaped by a focus on molecular pathology rather than histopathology. We re-classified 82 glial tumours according to the
The WHO Classification of Tumours of the Central Nervous System, 4th edition.
  • G. Fuller
  • Medicine
    Archives of pathology & laboratory medicine
  • 2008
TLDR
The recently revised WHO Classification of Tumours of the Central Nervous System (4th edition, 2007) follows in the highly successful footsteps of previous editions of this widely used reference and serves as the recommended reference standard for central nervous system tumor research studies and clinical protocols.
New WHO Classification of Brain Tumors
TLDR
The last (fourth) edition of WHO classification of tumours of the central nervous system (CNS) has been introduced in 2007 and preliminary codes were introduced for several new entities and variants.
Pathology, Epidemiology, and WHO Classification of Brain Tumors
TLDR
Increasing availability of reliable surrogate immunohistochemical antibodies appears as a promising alternative to overcome these challenges with respect to testing and reporting.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 73 REFERENCES
The New WHO Classification of Brain Tumours
The new edition of the World Health Organization (WHO) book on ‘Histological Typing of Tumours of the Central Nervous System’ reflects the progress in brain tumour classification which has been
WHO classification of tumours of the central nervous system
TLDR
The current edition of the WHO Classification of Tumours of the Central Nervous System will serve as an indispensable textbook for all of those involved in the diagnosis and management of patients with tumors of the CNS, and will make a valuable addition to libraries in pathology, radiology, oncology, and neurosurgery departments.
Revising the World Health Organization (WHO) Blue Book—‘Histological Typing of Tumours of the Central Nervous System’
  • P. Burger
  • Biology, Medicine
    Journal of Neuro-Oncology
  • 2005
Published in 1993, the second edition of the WHO 'Blue Book', 'Histological Typing of Tumours of the Central Nervous System', provides a worldwide standardization of terminology, classification, and
Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
TLDR
Findings indicate that LC/A morphological characteristics reflect a more advanced tumor stage than that found in pure medulloblastomas or in typical medullomyoblastoma.
Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas.
TLDR
Stratification of AOA, but not of pure AO, into grades 3 and 4 on the basis of necrosis is prognostically justified and is more powerful than the current approach.
Angiocentric Neuroepithelial Tumor (ANET): A New Epilepsy‐Related Clinicopathological Entity with Distinctive MRI
TLDR
A new clinicopathological entity within the spectrum of glioneuronal tumors observed in 10 children who underwent surgery for refractory epilepsy is reported, and the term angiocentric neuroepithelial tumor (ANET) is proposed.
Pigmented primitive neuroectodermal tumor with multipotential differentiation in cerebellum (pigmented medullomyoblastoma). A case with light- and electron-microscopic, and immunohistochemical analysis.
TLDR
A 5-year-old girl had a midline cerebellar primitive neuroectodermal tumor with neuronal, astrocytic, rhabdomyoblastic and melanocytic differentiation and the child died within 6 months.
Angiocentric Glioma: Report of Clinico-Pathologic and Genetic Findings in 8 Cases
TLDR
The findings support 2 previous reports proposing that angiocentric glioma is a novel glial tumor entity of low-grade malignancy.
Grading of astrocytomas: A simple and reproducible method
TLDR
In ordinary astrocytomas, each of the four histologic criteria, as well as the resultant grade, were strongly correlated to survival, and based upon the Cox Model, grade was found to be the major prognostic factor, superceding the effects of age, sex, and location.
Cerebellar medullomyoblastoma with advanced neuronal differentiation and hamartomatous component
TLDR
Investigation showed a highly cellular and predominantly undifferentiated tumor which developed in the cerebellar vermis of a 6-year-old girl, and evidence of advanced neuronal differentiation, with expression of neuron-specific enolase, synaptophysin, retinal S-antigen, and the formation of ganglioid tumor cells.
...
1
2
3
4
5
...